✦ LIBER ✦

Genetic Engineering, Expression, and Activity of a Chimeric Monoclonal Antibody−Avidin Fusion Protein for Receptor-Mediated Delivery of Biotinylated Drugs in Humans

✍ Scribed by Boado, Ruben J.; Zhang, Yufeng; Zhang, Yun; Xia, Chun-fang; Wang, Yuntao; Pardridge, William M.

Book ID: 126962257
Publisher: American Chemical Society
Year: 2008
Tongue: English
Weight: 687 KB
Volume: 19
Category: Article
ISSN: 1043-1802
DOI: 10.1021/bc7004076

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Engineering and expression of a chimeric

Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood–brain barrier delivery in the mouse

✍ Ruben J. Boado; Yun Zhang; Yuntao Wang; William M. Pardridge 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 2 views

## Abstract Protein therapeutics may be delivered across the blood–brain barrier (BBB) by genetic fusion to a BBB molecular Trojan horse. The latter is an endogenous peptide or a peptidomimetic monoclonal antibody (MAb) against a BBB receptor, such as the insulin receptor or the transferrin recepto

Genetic engineering, expression, and act

Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood–brain barrier

✍ Ruben J. Boado; Yufeng Zhang; Yun Zhang; William M. Pardridge 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 2 views

## Abstract Neurotrophins, such as brain derived neurotrophic factor (BDNF), do not cross the blood–brain barrier (BBB). Certain monoclonal antibodies (MAb) to the human insulin receptor (HIR) do cross the BBB via receptor‐mediated transport, and can act as a molecular Trojan horse to ferry across